Instillation of Gemcitabine in Patients With Superficial Bladder Cancer

NCT00191477 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

355

Enrollment

INDUSTRY

Sponsor class

Stopped The study was stopped early for futility reasons.

Conditions

Bladder Neoplasms

Interventions

DRUG: Gemcitabine
DRUG: Placebo

Sponsor

Eli Lilly and Company